- Home
- NVCT vs FORR Comparison
NVCT vs FORR Comparison
Compare NVCT & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | FORR |
|---|---|---|
| Founded | 2020 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.4M | 154.9M |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NVCT | FORR |
|---|---|---|
| Price | $8.68 | $8.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | 70.7K | ★ 90.3K |
| Earning Date | 02-24-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $403,871,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.55 | $6.60 |
| 52 Week High | $11.52 | $15.80 |
Technical Indicators
Market Signals| Indicator | NVCT | FORR |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 55.14 |
| Support Level | $8.08 | $7.92 |
| Resistance Level | $8.93 | $8.32 |
| Average True Range (ATR) | 0.51 | 0.26 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 36.45 | 24.66 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.